Skip to main content
SpringerLink
Log in

UGT1A1 genotyping prior to irinotecan therapy cost saving

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Butzke B, et al. Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan. 17th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes : abstr. PCN167, 8 Nov 2014. Available from: URL: http://www.ispor.org/RESEARCH_STUDY_DIGEST/list.asp?qs=39728.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

UGT1A1 genotyping prior to irinotecan therapy cost saving. PharmacoEcon Outcomes News 717, 37 (2014). https://doi.org/10.1007/s40274-014-1762-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1762-6

Search

Navigation